Validation of BARC Bleeding Criteria in Patients with Acute Coronary Syndromes the TRACER Trial

Journal of the American College of Cardiology

Volumn 67, Issue 18, 2016, Pages 2135-2144

  Vranckx, Pascal ^a   White, Harvey D ^b   Huang, Zhen ^c   Mahaffey, Kenneth W ^d   Armstrong, Paul W ^e   Van De Werf, Frans ^f   Moliterno, David J ^g   Wallentin, Lars ^h   Held, Claes ^h   Aylward, Philip E ⁱ   Cornel, Jan H ^j   Bode, Christoph ^k   Huber, Kurt ^l   Nicolau, José C ^m   Ruzyllo, Witold ⁿ   Harrington, Robert A ^d   Tricoci, Pierluigi ^c  

^a Hartcentrum Hasselt   (Belgium)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g UNIVERSITY OF KENTUCKY   (United States)

^h UPPSALA UNIVERSITY   (Sweden)

ⁱ FLINDERS UNIVERSITY   (Australia)

^j Medical Centre Alkmaar   (Netherlands)

^k UNIVERSITY OF FREIBURG   (Germany)

^l WILHELMINEN HOSPITAL   (Austria)

^m UNIVERSITY OF SÃO PAULO   (Brazil)

ⁿ INSTITUTE OF CARDIOLOGY   (Poland)

more..

Author keywords

aspirin; Bleeding Academic Research Consortium; clopidogrel; mortality; vorapaxar

Indexed keywords

PLACEBO; VORAPAXAR; ANTITHROMBOCYTIC AGENT; LACTONE; PYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; BLEEDING ACADEMIC RESEARCH CONSORTIUM SCALE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; VALIDATION PROCESS; CLASSIFICATION; CLINICAL TRIAL; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENT; STROKE; VALIDATION STUDY;

ACUTE CORONARY SYNDROME; AGED; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HEMORRHAGE; HUMANS; LACTONES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PYRIDINES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; STROKE;

EID: 84966642024     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.02.056     Document Type: Article

References (15)

1. G.W. Stone, A. Maehara, A.J. Lansky, and et al. A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
2. P.A. Merlini, K.A. Bauer, L. Oltrona, and et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction Circulation 90 1994 61 68
3. R. Mehran, S.V. Rao, D.L. Bhatt, and et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
4. G. Ndrepepa, T. Schuster, M. Hadamitzky, and et al. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention Circulation 125 2012 1424 1431
5. P. Vranckx, S. Leonardi, M. Tebaldi, and et al. Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial Eur Heart J 35 2014 2524 2529
6. TRA∗CER Executive and Steering Committees The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA∗CER) trial: study design and rationale Am Heart J 158 2009 327 334
7. P. Tricoci, Z. Huang, C. Held, and et al. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
8. J.L. Anderson, C.D. Adams, E.M. Antman, and et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 61 2013 e179 e347
9. J.P. Bassand, C.W. Hamm, D. Ardissino, and et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators N Engl J Med 329 1993 673 682
11. A.K. Rao, C. Pratt, A. Berke, and et al. Thrombolysis in Myocardial Infarction (TIMI) Trial - phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11
12. U.S. Food and Drug Administration. Guidance for Industry: Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring. August 2013. Available at: http://www.fda.gov/downloads/Drugs/./Guidances/UCM269919.pdf. Accessed March 4, 2016.
13. G. Ducrocq, P.J. Schulte, R.C. Becker, and et al. Association of spontaneous and procedure-related bleeds with short- and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial EuroIntervention 11 2015 737 745
14. A.P. Amin, A. Bachuwar, K.J. Reid, and et al. Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status J Am Coll Cardiol 61 2013 2130 2138
15. W. Hochholzer, S.D. Wiviott, E.M. Antman, and et al. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel - Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) Circulation 123 2011 2681 2689